Emerging research highlights the promise of metabolic peptides and dual agonists to reshape therapeutic interventions for metabolic diseases. These novel compounds offer the unique feature to simultaneously stimulate multiple pathways, circumventing the challenges of traditional isolated treatments. By fine-tuning tissue signaling, they can improve